Table 1.
Baseline characteristics of patient with renal cell carcinoma
| Characteristics | SOX9 (+) (%) | SOX9 (-) (%) | Total | P value |
|---|---|---|---|---|
| Age (y) | 0.61 | |||
| ≥ 70 | 9 (52.9) | 8 (47.1) | 17 | |
| < 70 | 56 (45.2) | 68 (54.8) | 124 | |
| Gender | 0.008 | |||
| Male | 48 (53.9) | 41 (46) | 89 | |
| Female | 16 (30.8) | 36 (69.2) | 52 | |
| Fuhrman grading | 0.012 | |||
| ≤ 2 | 24 (33.8) | 47 (66.2) | 71 | |
| > 2 | 41 (58.6) | 29 (41.4) | 70 | |
| T staging | 0.381 | |||
| ≤ 2 | 43 (55.8) | 34 (44.2) | 77 | |
| > 2 | 31 (48.4) | 33 (51.6) | 64 | |
| Metastasis | 16 (42.1) | 22 (57.9) | 38 |
NOTE: SOX9 (+) was defined as moderate to strong immunostaining signal (nuclear positive). P values were determined by Fisher’s exact test.